JIANG Bin, LIAO Peng-jun. Gemtuzumab Ozogamicin Significantly Improve Overall Survival in Elderly Patients with Acute Myeloid Leukemia[J]. Journal of Evidence-Based Medicine, 2017, 17(2): 85-87. DOI: 10.12019/j.issn.1671-5144.2017.02.007
Citation:
|
JIANG Bin, LIAO Peng-jun. Gemtuzumab Ozogamicin Significantly Improve Overall Survival in Elderly Patients with Acute Myeloid Leukemia[J]. Journal of Evidence-Based Medicine, 2017, 17(2): 85-87. DOI: 10.12019/j.issn.1671-5144.2017.02.007
|
JIANG Bin, LIAO Peng-jun. Gemtuzumab Ozogamicin Significantly Improve Overall Survival in Elderly Patients with Acute Myeloid Leukemia[J]. Journal of Evidence-Based Medicine, 2017, 17(2): 85-87. DOI: 10.12019/j.issn.1671-5144.2017.02.007
Citation:
|
JIANG Bin, LIAO Peng-jun. Gemtuzumab Ozogamicin Significantly Improve Overall Survival in Elderly Patients with Acute Myeloid Leukemia[J]. Journal of Evidence-Based Medicine, 2017, 17(2): 85-87. DOI: 10.12019/j.issn.1671-5144.2017.02.007
|